Cargando…

Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinoma

BACKGROUND: Renal medullary carcinoma (RMC) is a rare kidney tumor that occurs in adolescent and young adults, typically in association with sickle cell trait. RMC exhibits rapid disease progression, frequent metastases at diagnosis, and dismal clinical outcomes. Currently available therapies, inclu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beckermann, Kathryn E., Jolly, Pradeep C., Kim, Ju Y., Bordeaux, Jennifer, Puzanov, Igor, Rathmell, W. Kimryn, Johnson, Douglas B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240268/ https://www.ncbi.nlm.nih.gov/pubmed/28105368 http://dx.doi.org/10.1186/s40425-016-0206-1

Ejemplares similares

Modeling Clear Cell Renal Cell Carcinoma and Therapeutic Implications
por: Wolf, Melissa M., et al.
Publicado: (2020)

OPtimal Treatment by Invoking biologic clusters in renal cell carcinoma (OPTIC RCC)
por: Beckermann, Kathryn, et al.
Publicado: (2023)

Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma
por: Shiuan, Eileen, et al.
Publicado: (2021)

Renal cell carcinoma
por: Jonasch, Eric, et al.
Publicado: (2014)

Systematic Review: ClearCode 34 – A Validated Prognostic Signature in Clear Cell Renal Cell Carcinoma (ccRCC)
por: Ghatalia, Pooja, et al.
Publicado: (2018)

Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma
por: Tucker, Matthew D., et al.
Publicado: (2021)

Genomics of chromophobe renal cell carcinoma: implications from a rare tumor for pan-cancer studies
por: Rathmell, Kimryn W., et al.
Publicado: (2015)

HIF1α and HIF2α Exert Distinct Nutrient Preferences in Renal Cells
por: Arreola, Alexandra, et al.
Publicado: (2014)

FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer
por: Chen, James L, et al.
Publicado: (2013)

A Case Report of Severe Type B Lactic Acidosis Following First Dose of Nivolumab in a VHL-Mutated Metastatic Renal Cell Carcinoma
por: Nakajima, Erica, et al.
Publicado: (2017)

VHL Type 2B Mutations Retain VBC Complex Form and Function
por: Hacker, Kathryn E., et al.
Publicado: (2008)

The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy
por: Lim, Aaron R, et al.
Publicado: (2020)

Predictive role of PD-L1 expression in the response of renal Medullary carcinoma to PD-1 inhibition
por: Sodji, Quaovi, et al.
Publicado: (2017)

The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma
por: Chen, Yu-Wei, et al.
Publicado: (2022)

Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors
por: Switzer, Benjamin, et al.
Publicado: (2021)

Untangling ccRCC prognosis with SLINKY
por: Reinfeld, Bradley I., et al.
Publicado: (2017)

COVID-19 impact on early career investigators: a call for action
por: Levine, Ross L., et al.
Publicado: (2020)

Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction
por: Kanz, Bridgette A., et al.
Publicado: (2016)

Irradiation enhanced the effects of PD-1 blockade in brain metastatic osteosarcoma
por: Xia, Liming, et al.
Publicado: (2018)

The therapeutic implications of immunosuppressive tumor aerobic glycolysis
por: Reinfeld, Bradley I., et al.
Publicado: (2021)

Noncoding RNA blockade of autophagy is therapeutic in medullary thyroid cancer
por: Gundara, Justin S, et al.
Publicado: (2015)

Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinoma
por: Wood, Christopher G., et al.
Publicado: (2020)

Complete Pathologic Responses With Immunotherapy in Metastatic Renal Cell Carcinoma: Case Reports
por: Tucker, Matthew D., et al.
Publicado: (2020)

Racial difference in histologic subtype of renal cell carcinoma
por: Olshan, Andrew F, et al.
Publicado: (2013)

CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammation
por: Beckermann, Kathryn E., et al.
Publicado: (2020)

Imaging of Renal Medullary Carcinoma
por: Greco, Federico, et al.
Publicado: (2017)

PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma
por: Liu, Xian-De, et al.
Publicado: (2020)

Low intratumor heterogeneity correlates with increased response to PD-1 blockade in renal cell carcinoma
por: Ran, Xia, et al.
Publicado: (2020)

Role of 20-Hydroxyeicosatetraenoic Acid in Mediating Hypertension in Response to Chronic Renal Medullary Endothelin Type B Receptor Blockade
por: Speed, Joshua S., et al.
Publicado: (2011)

Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
por: Degrauwe, Nils, et al.
Publicado: (2012)

Cabozantinib for the Treatment of Metastatic Medullary Thyroid Carcinoma
por: Nix, Nancy M., et al.
Publicado: (2014)

Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer
por: Maron, Steven B., et al.
Publicado: (2023)

Pleiotropic Effects of the Trichloroethylene-Associated P81S VHL Mutation on Metabolism, Apoptosis, and ATM-Mediated DNA Damage Response
por: DeSimone, Michelle C., et al.
Publicado: (2013)

Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytes
por: Robert, Lidia, et al.
Publicado: (2014)

Targeting the mTOR pathway uncouples the efficacy and toxicity of PD-1 blockade in renal transplantation
por: Esfahani, Khashayar, et al.
Publicado: (2019)

Localized PD-1 Blockade in a Mouse Model of Renal Cell Carcinoma
por: Pham, Ngoc B., et al.
Publicado: (2022)

Response to radiation in renal medullary carcinoma
por: Walsh, Alexandra M., et al.
Publicado: (2011)

Endogenous Carbamylation of Renal Medullary Proteins
por: Claxton, J'Neka S., et al.
Publicado: (2013)

Renal medullary carcinoma with an ophthalmic metastasis
por: Ibilibor, Christine, et al.
Publicado: (2017)

Recent Advances in Renal Medullary Carcinoma
por: Su, Yongdong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i81dtvhjqgv1gi21kol6rg9vg0